Genmab A/S (GMAB)

NASDAQ: GMAB · IEX Real-Time Price · USD

28.70

+0.37 (1.31%)

Apr 19, 2024, 4:00 PM EDT - Market closed

Genmab Income Statement

Financials in millions DKK. Fiscal year is January - December.

Millions DKK. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017
Revenue	14,505	8,417	10,111	5,366	3,025	2,365
Revenue Growth (YoY)	72.33%	-16.75%	88.43%	77.39%	27.91%	-
Gross Profit	14,505	8,417	10,111	5,366	3,025	2,365
Selling, General & Admin	2,676	1,283	661	342	214	147
Research & Development	5,562	4,181	3,137	2,386	1,431	874
Operating Expenses	8,238	5,464	3,798	2,728	1,645	1,021
Operating Income	6,267	2,953	6,313	2,638	1,380	1,344
Interest Expense / Income	680	702	1,558	7	11	352
Other Expense / Income	-1,358	-1,667	-1,149	-228	-243	-72
Pretax Income	6,945	3,918	5,904	2,859	1,612	1,064
Income Tax	1,493	961	1,146	693	140	-40
Net Income	5,452	2,957	4,758	2,166	1,472	1,104
Net Income Growth	84.38%	-37.85%	119.67%	47.15%	33.33%	-
Shares Outstanding (Basic)	66	66	65	64	64	-
Shares Change	0.32%	0.84%	1.20%	-	-	-
EPS (Basic)	8.34	4.52	7.30	3.44	2.40	1.81
EPS (Diluted)	8.26	4.48	7.22	3.40	2.37	1.78
EPS Growth	84.48%	-38.00%	112.20%	43.40%	33.54%	-
Free Cash Flow	3,595	1,976	6,126	1,215	537	1,500
Free Cash Flow Per Share	5.46	3.01	9.41	1.89	0.83	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	43.21%	35.08%	62.44%	49.16%	45.62%	56.83%
Profit Margin	37.59%	35.13%	47.06%	40.37%	48.66%	46.68%
Free Cash Flow Margin	24.78%	23.48%	60.59%	22.64%	17.75%	63.42%
Effective Tax Rate	21.50%	24.53%	19.41%	24.24%	8.68%	-3.76%
EBITDA	-	-	-	2,866	1,623	1,416
EBITDA Margin	-	-	-	53.41%	53.65%	59.87%
EBIT	7,625	4,620	7,462	2,866	1,623	1,416
EBIT Margin	52.57%	54.89%	73.80%	53.41%	53.65%	59.87%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).